Clinical Evaluation of a Multi-target Fluorescent in Situ Hybridization Assay for Detection of Bladder Cancer
- 1 November 2002
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 168 (5) , 1950-1954
- https://doi.org/10.1016/s0022-5347(05)64270-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Upper-Tract Tumors After an Initial Diagnosis of Bladder Cancer: Argument for Long-Term SurveillanceJournal of Clinical Oncology, 2001
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Bladder cancer: state-of-the-art care.CA: A Cancer Journal for Clinicians, 1998
- CAN URINE BOUND DIAGNOSTIC TESTS REPLACE CYSTOSCOPY IN THE MANAGEMENT OF BLADDER CANCER?Journal of Urology, 1998
- Bladder Wash Cytology, Quantitative Cytology, and the Qualitative BTA Test in Patients with Superficial Bladder CancerUrology, 1998
- Improved detection of recurrent bladder cancer using the bard bta stat testUrology, 1997
- Urinary Nuclear Matrix Protein as a Marker for Transitional Cell Carcinoma of the Urinary TractJournal of Urology, 1996
- Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: A five-year follow-upUrology, 1995
- Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder CancerJournal of Urology, 1995
- Urine Cytology in the Detection of Bladder Cancer: A Critical ApproachJournal of Occupational and Environmental Medicine, 1990